Ovarian cancer esmo data (excluding asco 2019)

Companies listed will be included in either the Asco or the Esmo report (or both). Astrazeneca, Abbvie, Merck, Rospharmtech, Oncomax, Roche, Boehringer, GINECO, BMS, Tesaro, Genelux, Eli lilly, Immunogen, GSK, South Korean institutions, Indian institutions, Japanese institutions, German institutions, Romanian, French, MexicanAveo, Natera, Syndax, Aldeyra Therapeutics, Madrigal, Genmab, Flatiron, MD Anderson, Eisai, VBL, Otsuka, Mundipharma, National Cancer database, Cold Spring Harbour, Oriprint, Clovis, Regenacy, Arcus Biosciences, Gamamabs, 3-D medicines, Aravive*, Philips research, Fujifilm Pharmaceuticals, Nucana, Oncoimmunity, Fujifilm Pharmaceuticals, Sierra oncology, Zai Labs 

By purchasing or reading this report, you accept that we are not liable for errors. To be more relevant we try and release the report as soon as possible. We perform many reasonability checks and 'clean' the data, but errors can occur. No reliances should be made for medical purposes. 

If there is no company responsible for the data we list the nearest association